The medical data analytics platform has raised $5m from Merck Global Health Innovation Fund, adding to $23m raised last year.

Pharmaceutical firm Merck & Co’s Merck Global Health Innovation Fund has added $5m to a series D round for US-based precision medicine provider GNS Healthcare that now totals $28m. Founded in 2000, GNS has developed artificial intelligence software that processes a range of data, enabling users to build causal models in order to predict how…

The rest of this content is only accessible to Subscribers.

This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.